These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8646287)

  • 1. Blood transfusion in beta thalassaemia major.
    Rebulla P
    Transfus Med; 1995 Dec; 5(4):247-58. PubMed ID: 8646287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
    Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
    J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell antigen phenotypes in blood donors & thalassaemia patients for creation of red cell antigen-matched inventory.
    Kulkarni S; Choudhary B; Gogri H; Sharma J; Madkaikar M
    Indian J Med Res; 2020 Sep; 152(3):273-279. PubMed ID: 33107487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major.
    Prati D
    Vox Sang; 2000; 79(3):129-37. PubMed ID: 11111230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody screening in multitransfused patients: a prerequisite before each transfusion.
    Lamba DS; Mittal K; Sood T; Bedi RK; Kaur P; Kaur G
    Transfus Apher Sci; 2014 Oct; 51(2):132-3. PubMed ID: 25294114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions.
    Mourad Z; Hassab H; Younan D; Abdo A
    Transfus Med; 2015 Dec; 25(6):380-4. PubMed ID: 26578338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of blood transfusions in β-thalassemia.
    Shah FT; Sayani F; Trompeter S; Drasar E; Piga A
    Blood Rev; 2019 Sep; 37():100588. PubMed ID: 31324412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
    Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
    Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping of blood groups in alloimmunized patients with β-thalassemia major by T-ARMS-PCR and multiplex-aso-pcr.
    Gholami MS; Shahidi M; Tabibian S; Naderi M; Dorgalaleh A
    Transfus Apher Sci; 2021 Feb; 60(1):102984. PubMed ID: 33221123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Roberts DJ; Rees D; Howard J; Hyde C; Alderson P; Brunskill S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004450. PubMed ID: 16235363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion practices and complications in thalassemia.
    Lal A; Wong TE; Andrews J; Balasa VV; Chung JH; Forester CM; Ikeda AK; Keel SB; Pagano MB; Puthenveetil G; Shah SJ; Yu JC; Vichinsky EP
    Transfusion; 2018 Dec; 58(12):2826-2835. PubMed ID: 30260477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of red cell allo- and autoimmunization in patients with transfusion-dependent beta thalassemia and affecting factors.
    Koçyiğit C; Eliaçık K; Kanık A; Atabay B; Türker M
    Turk J Pediatr; 2014; 56(5):487-92. PubMed ID: 26022583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major.
    De Sanctis V; Katz M; Vullo C; Bagni B; Ughi M; Wonke B
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):791-8. PubMed ID: 8033371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
    Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
    Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of prevalence of red cell alloantibodies in patients with Beta Thalassaemia Major in Sri Lanka.
    Senavirathna SK; Ranasinghe SL; Thilakarathne YK
    Ceylon Med J; 2021 Jun; 66(2):96-99. PubMed ID: 35569017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β-thalassemia during perinatal transfusion.
    Wu Y; Ji Y; Dai B; Guo F; Wu Y; He Z; Mo C; Wu S; Hu Y
    Transfus Med; 2021 Feb; 31(1):24-29. PubMed ID: 33331032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt.
    Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
    Transfus Apher Sci; 2015 Aug; 53(1):52-7. PubMed ID: 25817267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.